Porcilis® PCV M Hyo-Field efficacy studies from six European and three Asian countries.
ĐoạnĐịnh dạng 16px
Porcilis® PCV M Hyo – It’s easy. It’s safe. It works.
Field efficacy studies from six European and three Asian countries.
In six European and three Asian countries, Porcilis® PCV M Hyo field efficacy was compared against a competitor vaccine and a control group.
Results field efficacy studies
Primary observations from the six studies
Porcilis PCV M Hyo:
• Improved average daily gain during the finishing phase
• Reduced the severity of lung lesion scores
• Reduced PCV2 viremia
• Induced a strong PCV2 and Mycoplasma hyopneumoniae humoral and cell mediated response
• Increased revenue per pig
Time to say yes to Porcilis® PCV M Hyo!
It’s easy. It’s safe. It works.
Detail information:Click Here